Concepedia

Publication | Open Access

Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease

163

Citations

33

References

2019

Year

Abstract

Our results encourage an independent validation cohort study to confirm the indication that the plasma Aβ<sub>1-40</sub>/Aβ<sub>1-42</sub> ratio, assessed via Simoa, may improve future standard of care and clinical trial design.

References

YearCitations

Page 1